Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_assertion type Assertion NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_head.
- NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_assertion description "[Amplification of ERBB-2 was detected in 14 out of 63 (22%) cases of breast carcinoma, in 1 out of 23 patients with ovarian cancers, in 1 out of 19 cases of colon carcinoma and in 1 out of 27 patients with thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_provenance.
- NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_assertion evidence source_evidence_literature NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_provenance.
- NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_assertion SIO_000772 1349430 NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_provenance.
- NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_assertion wasDerivedFrom befree-20150227 NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_provenance.
- NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_assertion wasGeneratedBy ECO_0000203 NP378781.RAYu-SS6zZRr3BZBP8cUUhwds9yPQmnV33-p81DzlDAkY130_provenance.